SLS · Forms 3, 4, 5
Insider trades at SELLAS Life Sciences Group, Inc.
No open-market insider buys or sells at SELLAS Life Sciences Group, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for SELLAS Life Sciences Group, Inc. (SLS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for SELLAS Life Sciences Group, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Angelos M. Stergiou | President and CEO | Award | 1,065,000 | Form 4 | |||
| John Varian | Director | Award | 50,000 | Form 4 | |||
| Nostrand Robert L Van | Director | Award | 50,000 | Form 4 | |||
| David A Scheinberg | Director | Award | 50,000 | Form 4 | |||
| Dragan Cicic | SVP, Chief Development Officer | Award | 300,000 | Form 4 | |||
| John Thomas Burns | CFO | Award | 300,000 | Form 4 | |||
| Katherine Bach Kalin | Director | Award | 50,000 | Form 4 | |||
| Jane Wasman | Director | Award | 50,000 | Form 4 | |||
| Dragan Cicic | SVP, Chief Development Officer | Other | 63,800 | $1.50 | $96K | Form 4 | |
| John Thomas Burns | CFO | Other | 58,592 | $1.50 | $88K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.